What is Christine Hunt's NPI number?

Christine Hunt's National Provider Identifier (NPI) is 1366607194, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is Christine Hunt's specialty?

Christine Hunt is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).

Where is Christine Hunt located?

Christine Hunt's practice location on file with NPPES is 4419 Crenshaw Rd, Pasadena, TX 77504-3628.

What is Christine Hunt's phone number?

The practice phone number listed in the NPPES registry for Christine Hunt is (281) 991-5944.

Does Christine Hunt accept Medicare?

Christine Hunt is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is Christine Hunt's NPI active?

Yes — Christine Hunt's NPI (1366607194) is active in the NPPES registry as of the last update on 2022-06-16.

IndividualActiveAccepts Medicare

Christine Hunt, M.D.

NPI 1366607194 · Dermatology Physician · Pasadena, TX

Christine Hunt, M.D. is a Dermatology Physician provider in Pasadena, TX (NPI 1366607194).

Provider details

NPI number: 1366607194
Entity type: Individual
Primary specialty: Dermatology PhysicianAllopathic & Osteopathic Physicians
Credential: M.D.
Sex: Female
Sole proprietor: No
License: P0231 (TX)

Practice location

4419 Crenshaw Rd

Pasadena, TX 77504-3628

Phone: (281) 991-5944

Street-level locationGet directions

More TX providers

Mailing address

4419 Crenshaw Rd

Pasadena, TX 77504-3628

Specialties & taxonomies

Dermatology PhysicianPrimary207N00000XLicense P0231 (TX)
Allopathic & Osteopathic Physicians

Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Detailed profile(77/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure25% of score
18 yrs in NPPES registry
Profile completeness25% of score
100% of core fields populated
Practice footprint15% of score
1 documented practice location
Medicare service volume (vs. specialty peers)25% of score
2,894 Medicare services, 2024 (ranked within specialty)
Open Payments transparency10% of score
Has Open Payments disclosures (2024)

Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	1,270	$7
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	434	$96
Destruction of Precancer Skin Growth, 1 Growth17000	253	$52
Destruction of Skin Growth, 1-14 Growths17110	252	$115
Biopsy of Related Skin Growth, First Growth11102	201	$85
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 30 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Triamcinolone Acetonide	175	112
Clobetasol Propionate	162	84
Minoxidil	156	63
Ketoconazole	134	53
Dutasteride	97	41
Doxycycline Hyclate	90	44
Metronidazole	88	45
Mometasone Furoate	87	52

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$5,781 across 223 records (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2008-07-21
Last updated: 2022-06-16
Certified: 2022-06-16

Frequently asked questions

What is Christine Hunt's NPI number?: Christine Hunt's National Provider Identifier (NPI) is 1366607194, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is Christine Hunt's specialty?: Christine Hunt is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).
Where is Christine Hunt located?: Christine Hunt's practice location on file with NPPES is 4419 Crenshaw Rd, Pasadena, TX 77504-3628.
What is Christine Hunt's phone number?: The practice phone number listed in the NPPES registry for Christine Hunt is (281) 991-5944.
Does Christine Hunt accept Medicare?: Christine Hunt is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is Christine Hunt's NPI active?: Yes — Christine Hunt's NPI (1366607194) is active in the NPPES registry as of the last update on 2022-06-16.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	1,270	$7
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	434	$96
Destruction of Precancer Skin Growth, 1 Growth17000	253	$52
Destruction of Skin Growth, 1-14 Growths17110	252	$115
Biopsy of Related Skin Growth, First Growth11102	201	$85
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More

Drug

Part D claims (2024)

Beneficiaries

Triamcinolone Acetonide

175

112

Clobetasol Propionate

162

Minoxidil

156

Ketoconazole

134

Dutasteride

Doxycycline Hyclate

Metronidazole

Mometasone Furoate

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$5,781 across 223 records (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments